These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 3125510

  • 1. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W, Muntean W.
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [Abstract] [Full Text] [Related]

  • 2. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 3. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 4. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
    Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenbjerg S, Knudsen JB.
    Thromb Haemost; 1987 Dec 18; 58(4):1049-52. PubMed ID: 3127918
    [Abstract] [Full Text] [Related]

  • 5. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994 Dec 18; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 6. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A, Kavakli K, Baytan B, Kazanci E, Sayli T, Oren H, Celkan T, Gursel T.
    Haemophilia; 2008 Mar 18; 14(2):315-22. PubMed ID: 18081830
    [Abstract] [Full Text] [Related]

  • 7. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
    Guérois C, Laurian Y, Rothschild C, Parquet-Gernez A, Duclos AM, Négrier C, Vicariot M, Fimbel B, Fressinaud E, Fiks-Sigaud M.
    Thromb Haemost; 1995 Feb 18; 73(2):215-8. PubMed ID: 7792732
    [Abstract] [Full Text] [Related]

  • 8. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J.
    Haematologica; 2000 Oct 18; 85(10 Suppl):15-20. PubMed ID: 11187863
    [Abstract] [Full Text] [Related]

  • 9. Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.
    Sultan Y, White GC, Aronstam A, Bosser C, Brackmann HH, Brochier G, Gormsen J, Mariani G, Roberts HR, Scarabin Y.
    Nouv Rev Fr Hematol (1978); 1986 Oct 18; 28(2):85-9. PubMed ID: 3090516
    [Abstract] [Full Text] [Related]

  • 10. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C, Patharathienskul D, Suvatte V.
    Southeast Asian J Trop Med Public Health; 1993 Oct 18; 24 Suppl 1():106-12. PubMed ID: 7886549
    [Abstract] [Full Text] [Related]

  • 11. [Transient inhibitors developed in two cases of hemophilia A].
    Fujiwara F, Kanoh G, Ogawa H, Takaya K, Hibi S, Shima M, Yoshioka A, Imashuku S.
    Rinsho Ketsueki; 1997 Dec 18; 38(12):1263-8. PubMed ID: 9455145
    [Abstract] [Full Text] [Related]

  • 12. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R, Rocino A, Papa ML, Salerno E, Mastrullo L, De Blasi D.
    Thromb Haemost; 1994 May 18; 71(5):544-7. PubMed ID: 8091377
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
    Kreuz W, Becker S, Lenz E, Martinez-Saguer I, Escuriola-Ettingshausen C, Funk M, Ehrenforth S, Auerswald G, Kornhuber B.
    Semin Thromb Hemost; 1995 May 18; 21(4):382-9. PubMed ID: 8747701
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 May 18; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 15. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ, Dias Francisco F, Tavares ML, Leal I.
    Acta Med Port; 1992 Apr 18; 5(4):178-80. PubMed ID: 1605065
    [Abstract] [Full Text] [Related]

  • 16. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO, Dazzi H, von Felten A.
    Schweiz Med Wochenschr; 1995 Mar 04; 125(9):405-11. PubMed ID: 7892567
    [Abstract] [Full Text] [Related]

  • 17. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
    Berntorp E, Astermark J, Carlborg E.
    Haematologica; 2000 Oct 04; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
    [Abstract] [Full Text] [Related]

  • 18. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group.
    Haemophilia; 2007 Jul 04; 13(4):373-9. PubMed ID: 17610550
    [Abstract] [Full Text] [Related]

  • 19. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.
    Mauser-Bunschoten EP, Rosendaal FR, Nieuwenhuis HK, Roosendaal G, Briët E, van den Berg HM.
    Thromb Haemost; 1994 Jun 04; 71(6):703-6. PubMed ID: 7974335
    [Abstract] [Full Text] [Related]

  • 20. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R, de Cristofaro R, Lazzareschi I, Riccardi R, Mariani G.
    Haematologica; 2000 Oct 04; 85(10 Suppl):73-4. PubMed ID: 11187877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.